Onyx Biotec Ltd

NSE: ONYX · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹37.80
Market cap: ₹68.54 Cr
Revenue (annual): ₹69.47 Cr
Net profit (annual): ₹-0.21 Cr
P/E (TTM): -319.7×Sector 47.4×
Promoter holding: 65.10%
FII holding: 1.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling 3 Other Announcement 2 Management Change 2 Fund Raise 2 Financial Results 2 Price Movement Clarification 1 Open Offer 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 May 2026 17:45 IST NSE

Fund Raise

Onyx Biotec Fund Raise of ₹25.38 Cr

Onyx Biotec Limited confirmed zero deviation in utilizing ₹25.38 Crore raised through its IPO. Funds were deployed for manufacturing upgrades, loan repayments, and general corporate purposes.

Value: ₹25.38 Cr

Read the filing ↗

22 Apr 2026 11:20 IST NSE

Fund Raise

Onyx Biotec Fund Raise of ₹25.38 Cr

Onyx Biotec Limited submitted an auditor-signed certificate confirming the utilization of Rs. 25.38 Crore in IPO proceeds for the half-year ended September 30, 2025. The funds were utilized for manufacturing unit upgradation, loan repayment, and general corporate purposes, with no reported deviations from the stated objects.

Value: ₹25.38 Cr

Read the filing ↗